These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 22127228)

  • 1. Pyrrolidine dithiocarbamate enhances hepatic glycogen synthesis and reduces FoxO1-mediated gene transcription in type 2 diabetic rats.
    Zhu T; Zhao R; Zhang L; Bernier M; Liu J
    Am J Physiol Endocrinol Metab; 2012 Feb; 302(4):E409-16. PubMed ID: 22127228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyrrolidine dithiocarbamate protects pancreatic β-cells from oxidative damage through regulation of FoxO1 activity in type 2 diabetes rats.
    Ding H; Zhu T; Yin X; Liu J; Zhang L; Bernier M; Zhao R
    Acta Biochim Biophys Sin (Shanghai); 2014 Jul; 46(7):582-9. PubMed ID: 24829401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
    Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
    Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xanthosine, a purine glycoside mediates hepatic glucose homeostasis through inhibition of gluconeogenesis and activation of glycogenesis via regulating the AMPK/ FoxO1/AKT/GSK3β signaling cascade.
    Ahmed SA; Sarma P; Barge SR; Swargiary D; Devi GS; Borah JC
    Chem Biol Interact; 2023 Feb; 371():110347. PubMed ID: 36627075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
    Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
    Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
    Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
    Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spleen-kidney supplementing formula alleviates insulin resistance via regulating AKT/glycogen synthase kinase 3β pathway in rats with type 2 diabetic induced by high-fat diet.
    Tian C; Wang Y; La X; Li J; Zhang B
    J Tradit Chin Med; 2019 Apr; 39(2):199-206. PubMed ID: 32186042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endurance exercise training increases APPL1 expression and improves insulin signaling in the hepatic tissue of diet-induced obese mice, independently of weight loss.
    Marinho R; Ropelle ER; Cintra DE; De Souza CT; Da Silva AS; Bertoli FC; Colantonio E; D'Almeida V; Pauli JR
    J Cell Physiol; 2012 Jul; 227(7):2917-26. PubMed ID: 21938726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute exercise reduces hepatic glucose production through inhibition of the Foxo1/HNF-4alpha pathway in insulin resistant mice.
    De Souza CT; Frederico MJ; da Luz G; Cintra DE; Ropelle ER; Pauli JR; Velloso LA
    J Physiol; 2010 Jun; 588(Pt 12):2239-53. PubMed ID: 20421289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zhenqing recipe improves glucose metabolism and insulin sensitivity by repressing hepatic FOXO1 in type 2 diabetic rats.
    Huang W; Yu J; Jia X; Xiong L; Li N; Wen X
    Am J Chin Med; 2012; 40(4):721-33. PubMed ID: 22809027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
    Sajan MP; Ivey RA; Lee MC; Farese RV
    J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of octreotide on hepatic glycogenesis in rats with high fat diet‑induced obesity.
    Wang XX; Ye T; Li M; Li X; Qiang O; Tang CW; Liu R
    Mol Med Rep; 2017 Jul; 16(1):109-118. PubMed ID: 28534956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mibefradil reduces hepatic glucose output in HepG2 cells via Ca
    Ying D; Mengya S; Peilin L; Lingong Z; Huan M; Jing X; Le Z; Kebin Z; Bin C; Jun Y; Shaodong G; Zihui X
    Eur J Pharmacol; 2021 Sep; 907():174296. PubMed ID: 34224697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GSK3β regulates gluconeogenic gene expression through HNF4α and FOXO1.
    Sakamaki J; Daitoku H; Kaneko Y; Hagiwara A; Ueno K; Fukamizu A
    J Recept Signal Transduct Res; 2012 Apr; 32(2):96-101. PubMed ID: 22384829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 15-hydroxyprostaglandin dehydrogenase inhibitor SW033291 ameliorates abnormal hepatic glucose metabolism through PGE
    Liang M; Wang L; Wang W
    Cell Signal; 2023 Aug; 108():110707. PubMed ID: 37164143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The constitutive androstane receptor activator 4-[(4R,6R)-4,6-diphenyl-1,3-dioxan-2-yl]-N,N-dimethylaniline inhibits the gluconeogenic genes PEPCK and G6Pase through the suppression of HNF4α and FOXO1 transcriptional activity.
    Yarushkin AA; Kachaylo EM; Pustylnyak VO
    Br J Pharmacol; 2013 Apr; 168(8):1923-32. PubMed ID: 23231652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antioxidant pyrrolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia.
    Nurmi A; Goldsteins G; Närväinen J; Pihlaja R; Ahtoniemi T; Gröhn O; Koistinaho J
    Free Radic Biol Med; 2006 May; 40(10):1776-84. PubMed ID: 16678015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
    World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FOXO1 is downregulated in obese mice subjected to short-term strength training.
    Pereira RM; da Cruz Rodrigues KC; Sant'Ana MR; da Rocha AL; Morelli AP; Veras ASC; Gaspar RS; da Costa Fernandes CJ; Teixeira GR; Simabuco FM; da Silva ASR; Cintra DE; Ropelle ER; Pauli JR; de Moura LP
    J Cell Physiol; 2022 Nov; 237(11):4262-4274. PubMed ID: 36125908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of GSK-3 selectively reduces glucose-6-phosphatase and phosphatase and phosphoenolypyruvate carboxykinase gene expression.
    Lochhead PA; Coghlan M; Rice SQ; Sutherland C
    Diabetes; 2001 May; 50(5):937-46. PubMed ID: 11334436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.